.DeLaGhettoReal enters a new era with ‘GZ,’ his first studio album as an indie artist. Read his interview with Billboard:
“The creative process was a little bit different because we weren’t going to do this album. We just wanted to drop singles, but my manager put the pressure on me,” De La Ghetto tells. “The vibe was different because this is the first album I’ve dropped as an independent artist, so there was more motivation. I didn’t have a crazy deadline, there was no pressure, I just flowed and was having fun with the album.”, released in 2020 before parting ways with Warner Music Latina.
“Sometimes the old-school producers, as great as they are, are drained from doing a lot of work. I wanted to bring that new energy, that new sound from Puerto Rico to the world — I wanted to use the people from my island without taking credit away from the artists in Colombia, Argentina and the Dominican Republic,” he explains. “When I work with new artists, I let them take control. When we’re in the studio, I let them lead and show me what they want to hear from the new De La Ghetto.
“That’s why I took sometime after ‘Los Chulitos’ to release a new album because I was by myself, I was independent, and I was trying to find that passion of mine to create music,” he says. “What’s the point of releasing an album without feeling? I couldn’t just drop an album with no purpose. It’s not in my DNA.”
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
De La Ghetto Is Ushering in a New Era of Latin R&B on 'GZ'Puerto Rican music veteran DeLaGhettoReal talks about teaming up with MYKETOWERS (who he almost signed at one point), being blown away by rainaopr, and making his exciting new album 'GZ.'
続きを読む »
AI-discovered drug enters Phase II trials, first patients dosed in the US, ChinaAI can be leveraged to bring down the time and money spent on the drug discovery process, shortening time to treatment availability and improving chances of success.
続きを読む »
First AI-generated drug enters human clinical trials, targeting chronic lung disease patientsThe first drug ever generated by artificial intelligence has entered Phase 2 clinical trials with lung disease patients; the first dose was successfully administered to a human, Insilico Medicine announced.
続きを読む »
The First Fully A.I.-Generated Drug Enters Clinical Trials in Human PatientsThe drug was created as a treatment for idiopathic pulmonary fibrosis, a chronic disease that causes scarring in the lungs.
続きを読む »
New taxes, higher tolls, and more: These new laws take effect in Washington on July 1From taxes to tolls, here's what you need to look out for starting July 1.
続きを読む »
Sriracha sauce is selling for astronomically high prices amid shortageSummer may be heating up, but many restaurants and at-home chefs are struggling to bring the heat in the kitchen due to an ongoing Sriracha shortage.
続きを読む »